On Invalid Date, Flora Growth (NASDAQ: FLGC) reported Q4 2023 earnings per share (EPS) of -$0.82, up 72.94% year over year. Total Flora Growth earnings for the quarter were -$9.42 million. In the same quarter last year, Flora Growth's earnings per share (EPS) was -$3.03.
As of Q2 2024, Flora Growth's earnings has grown year over year. Flora Growth's earnings in the past year totalled -$56.35 million.
What was FLGC's revenue last quarter?
On Invalid Date, Flora Growth (NASDAQ: FLGC) reported Q4 2023 revenue of $17.98 million up 70.38% year over year. In the same quarter last year, Flora Growth's revenue was $10.55 million.
What was FLGC's revenue growth in the past year?
As of Q2 2024, Flora Growth's revenue has grown 127.75% year over year. This is 117.57 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.18%. Flora Growth's revenue in the past year totalled $76.07 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.